Related Experiment Video
Updated: May 4, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
14.4K
Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack
Brian S Katz1, Kelly D Flemming
1Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota.
Neurosurgical Focus
|January 2, 2014
Summary
Identifying and treating modifiable risk factors, alongside antithrombotic therapy, is key to preventing recurrent ischemic stroke. Neurosurgeons play a vital role in managing patients with cerebrovascular atherosclerosis.
Area of Science:
- Neurology
- Vascular Surgery
- Cardiology
Background:
- Recurrent ischemic stroke is a significant concern.
- Modifiable risk factors contribute to stroke recurrence.
- Antithrombotic therapy is a cornerstone of treatment.
Purpose of the Study:
- To review antithrombotic selection for cerebral ischemia.
- To discuss identification and secondary prevention of stroke risk factors.
- To highlight the role of neurosurgeons in managing atherosclerotic disease.
Main Methods:
- Literature review of antithrombotic indications.
- Discussion of secondary stroke prevention strategies.
- Focus on risk factors relevant to neurosurgical patients.
Main Results:
- Appropriate antithrombotic therapy reduces recurrent stroke risk.
- Targeting modifiable risk factors is crucial for secondary prevention.
- Neurosurgeons are integral to managing intracranial and extracranial atherosclerotic disease.
Conclusions:
- Comprehensive management of ischemic stroke involves antithrombotic therapy and risk factor modification.
- Neurosurgeons require knowledge of stroke risk factors and management.
- Effective secondary prevention strategies are essential to reduce stroke recurrence.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:26Transient Ischemic Attack l: Introduction
18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:30Venous Thrombosis IV: Nursing Management
415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415